XWELL, Inc. Stock

XWEL

US98420U8027

Personal Services

Market Closed - Nasdaq Other stock markets 00:00:00 02/07/2026 +04			5-day change	1st Jan Change
1.060 ^USD	+1.92%		-3.64%	+130.03%

05-21	XWELL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-02	Xwell registers resale of up to 138.7 million shares of common stock from time to time by selling stockholders - SEC filing	RE

Last Transcript: XWELL, Inc.

XWELL, Inc., Q2 2025 Earnings Call, Aug 14, 2025

15/08/25

More transcripts

Analysts' recommendations: XWELL, Inc.

04/04/23	HC Wainwright Trims XWELL's Price Target to $1 From $1.50, Keeps Buy Rating	MT
16/11/22	HC Wainwright Adjusts Price Target on XWELL to $1.50 From $2, Maintains Buy Rating	MT
18/05/22	HC Wainwright Adjusts Price Target on XpresSpa Group to $2 From $4, Reiterates Buy Rating	MT
17/11/21	HC Wainwright Adjusts Price Target on XpresSpa Group to $4 From $3.50, Reiterates Buy Rating	MT
16/02/21	XPRESSPA : HC Wainwright Starts XpresSpa Group at Buy With $3.50 Price Target	MT

More recommendations

News in other languages: XWELL, Inc.

30/09/20

Morning Briefing - International

More news

Managers and Directors: XWELL, Inc.

Manager	Title	Age	Since
Ezra Ernst CEO	Chief Executive Officer	57	04/09/2024
Thomas Brown DFI	Director of Finance/CFO	57	06/01/2025
Patti Ward COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Bruce Bernstein CHM	Chairman	62	01/02/2018
Robert Weinstein BRD	Director/Board Member	66	03/02/2020
Michael Lebowitz BRD	Director/Board Member	54	07/04/2020

More insiders

XWELL, Inc. is a global wellness company. The Company delivers restorative and health-focused services to travelers through its three operating segments: XpresSpa, XpresTest, and Naples Wax Center. XpresSpa operates spa service locations in major airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the Centers for Disease Control and Prevention's (CDC's) bio-surveillance program. The Naples Wax Center segment operates six locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. Its health wellness beauty services include massage, waxing, facials, stretch, light emitting diode (LED) light therapy, meditation, manicures, pedicures, aromatherapy, anti-aging treatments, compression therapy, and massage chairs. Its subsidiaries include Naples Wax FRM LLC, Quantum Stream Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and others.

Employees

228

Sector

Personal Services

More about the company

Quotes

Date	Price	Change	Volume
01/07/26	$1.060	+1.92%	34,652
30/06/26	$1.040	+0.97%	69,329
29/06/26	$1.030	-2.83%	28,588
26/06/26	$1.060	+1.92%	83,155
25/06/26	$1.040	-5.45%	93,692

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Market Cap	8.95M 7.86M 7.23M 6.74M 12.71M 851M 12.97M 87M 33.71M 418M 33.61M 32.88M 1.45B	P/E 2024	-0.41x	P/E 2025	-0.09x
Enterprise Value	18.81M 16.52M 15.2M 14.17M 26.72M 1.79B 27.26M 183M 70.86M 878M 70.64M 69.11M 3.06B	EV / Sales 2024	0.2x	EV / Sales 2025	0.43x
Free-Float	76.76%	Yield 2024 *	-	Yield 2025	-

05-21	XWELL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-02	Xwell registers resale of up to 138.7 million shares of common stock from time to time by selling stockholders - SEC filing	RE
04-01	XWELL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-25	Xwell announces approximately $31.3 million private placement priced at the market under Nasdaq rules	RE
02-24	XWELL, Inc. announced that it expects to receive $31.333 million in funding	CI
02-03	XWELL Inc. and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone	CI
01-08	Xwell, Inc. Appoints Cindy Friedman as Senior Advisor	CI
12-18	XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station	CI
11-15	Wellness services firm XWELL's Q3 operating loss narrows	RE
11-15	XWELL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-15	XWELL enters securities exchange and amendment agreement with Series G preferred stock holders - SEC filing	RE
11-05	XWELL and Ostrichpillow Launch Exclusive Co-Branded Eye Mask	CI
30/10/25	Xwell, Inc. Expands Priority Pass Partnership to Bring Wellness Worldwide	CI

04-02	XWELL Reports Fiscal 2025 Results	AQ
02-27	Nasdaq Small-Caps: SNYR, XWEL, FGL, FMFC, Surge Into 2026 Spotlight	AQ
02-25	XWELL : Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules	PU
02-25	XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules	AQ
02-03	XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone	AQ

1 day	+1.92%
1 week	-3.64%
Current month	+1.92%
1 month	-14.52%
3 months	-8.62%
6 months	+130.03%
Current year	+130.03%

1 week	1	1.17
1 month	1	1.54
Current year	0.26	2.2
1 year	0.26	2.2
3 years	0.26	6.4
5 years	0.26	43.8
10 years	0.26	4,860

XWELL, Inc. Stock

Stocks

XWEL

US98420U8027

Personal Services

Valuation: XWELL, Inc.

Chart: XWELL, Inc.

Latest news : XWELL, Inc.

Last Transcript: XWELL, Inc.

Analysts' recommendations: XWELL, Inc.

Press Releases: XWELL, Inc.

News in other languages: XWELL, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: XWELL, Inc.

Latest insider transactions

Personal Care Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
02-27	Gaëlle Wizenberg	Free	Director	100,000	1.7341%
02-27	Robert Weinstein	Free	Director	100,000	1.7341%
02-27	Michael Lebowitz	Free	Director	100,000	1.7341%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
XWELL, INC.	+1.92%	-3.64%	+15.22%	-73.59%	8.95M
FAMEGLOW HOLDINGS LIMITED	-0.35%	+5.24%	+987.79%	+3,375.61%	1.67B
BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.	-5.57%	-3.69%	-44.65%	-26.37%	536M
CONVANO INC.	+1.16%	+2.35%	+14.17%	+1,162.70%	270M
SKINKANDY LIMITED	+11.20%	+16.52%	-	-	186M
PERFECT MEDICAL HEALTH MANAGEMENT LIMITED	+10.19%	+12.26%	-29.17%	-69.17%	173M
SIAM WELLNESS GROUP	-0.61%	+4.46%	+7.19%	-58.31%	126M
AB&COMPANY CO.,LTD.	+0.99%	+4.73%	+40.23%	+10.57%	115M
QB NET HOLDINGS CO.,LTD.	-0.16%	+1.05%	+8.28%	-17.97%	105M
REGIS CORPORATION	-2.14%	+5.22%	+24.49%	+23.42%	68.47M
Average	+1.66%	+4.52%	+113.73%	+480.77%	325.86M
Weighted average by Cap.	+0.15%	+9.62%	+531.47%	+1,926.25%

	2024	2025
Net sales	33.9M 29.76M 27.39M 25.53M 48.14M 3.22B 49.12M 329M 128M 1.58B 127M 125M 5.51B	29.21M 25.65M 23.61M 22M 41.49M 2.78B 42.33M 284M 110M 1.36B 110M 107M 4.74B
Net income	-16.85M -14.8M -13.62M -12.69M -23.94M -1.6B -24.42M -164M -63.47M -786M -63.28M -61.91M -2.74B	-16.99M -14.92M -13.73M -12.8M -24.13M -1.62B -24.62M -165M -63.99M -793M -63.8M -62.42M -2.76B
Net Debt	-1.03M -904K -832K -776K -1.46M -97.92M -1.49M -10.01M -3.88M -48.07M -3.87M -3.78M -167M	9.86M 8.66M 7.97M 7.43M 14.01M 938M 14.29M 95.87M 37.15M 460M 37.03M 36.23M 1.6B